NCT06271044

a. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESS

Reducing Radioiodine Treatment in Low Risk Papillary Thyroid Cancer

• Status: Active Not Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 61 (actual)
• Sponsor: Helsinki University Central Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

To study if its is safe to reduce the amount of postoperative treatments in those patients, who have been operated on because of a low-risk intrathyroidal papillary thyroid cancer with diameter of 11-20mm, and in whom postoperative thyroglobulin levels are of low level.

Detailed description

The purpose of the study : to enroll about 50 patients operated on because of a low-risk intrathyroidal papillary thyroid cancer with diameter of 11-20mm, and in whom postoperative thyroglobulin levels are of low level. Methods: either to follow-up patients according to the study protocol without radioiodine treatment or to give a radioiodine treatment with a dose of 1.1 GBq according to the normal Finnish treatment protocol for papillary thyroid cancer to those patients who themselves preferred to have a normal postoperative treatment.

Conditions

• to Omit Radioiodine Treatment Safely in Patients With Low -Risk Papillary Thyroid Cancer With Seize of 11-20mm

Interventions

Type	Name	Description
OTHER	With radioiodine treatment	Postoperative radioiodine not given
PROCEDURE	With postoperative radioiodine treatment	Postoperative radioiodine given

Timeline

• Start date: 2014-10-01
• Primary completion: 2024-12-01
• Completion: 2027-12-31
• First posted: 2024-02-21
• Last updated: 2024-02-21